In vitiligo, The activation of TRM1, which exhibit the expression of effector molecules such as perforin and granzyme B upon stimulation with IL‐15, promotes a robust cytotoxic response, contributing to the pathogenesis of the disease [71]. This evidence concerns the gene IL15 and vitiligo.